California Recombinant Antibody is categorized under Commercial Biotechnical Research in Berkeley, CA and active since 2000.
California Recombinant Antibody was established in 2000, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact James D Marks at the company’s single location by writing to 107 Ardmore Road, Berkeley, California CA 94707 or by phoning (510) 527-5022. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | California Recombinant Antibody |
| Contact Person: | James D Marks |
| Address: | 107 Ardmore Road, Berkeley, California 94707 |
| Phone Number: | (510) 527-5022 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2000 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541711 |
| Share This Business: |
California Recombinant Antibody was started in 2000 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact James D Marks for inquiries that concern California Recombinant Antibody by calling the company number (510) 527-5022, as your correspondence is most welcome. Additionally, the physical location of the single location of California Recombinant Antibody can be found at the coordinates as well as the street address 107 Ardmore Road in Berkeley, California 94707.
For its online presence, you may visit California Recombinant Antibody’s website at and engage with its social media outlets through on Twitter and on Facebook.